🇺🇸 FDA
Patent

US 9598703

Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery

granted A61PA61P21/00A61P21/04

Quick answer

US patent 9598703 (Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P21/00, A61P21/04, A61P25/00, A61P25/08